OMERS Administration Corp’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.94M | Buy |
10,244
+1,300
| +15% | +$374K | 0.02% | 253 |
|
|
2025
Q1 | $2.76M | Buy |
8,944
+1,634
| +22% | +$504K | 0.02% | 273 |
|
|
2024
Q4 | $2.58M | Sell |
7,310
-3,802
| -34% | -$1.34M | 0.02% | 268 |
|
|
2024
Q3 | $3.98M | Sell |
11,112
-6,800
| -38% | -$2.44M | 0.04% | 198 |
|
|
2024
Q2 | $5.71M | Buy |
17,912
+15,412
| +616% | +$4.91M | 0.05% | 144 |
|
|
2024
Q1 | $574K | Hold |
2,500
| – | – | 0.01% | 196 |
|
|
2023
Q4 | $550K | Buy |
+2,500
| New | +$550K | 0.01% | 172 |
|
|
2019
Q2 | – | Sell |
-3,200
| Closed | -$389K | – | 481 |
|
|
2019
Q1 | $389K | Buy |
+3,200
| New | +$389K | ﹤0.01% | 313 |
|
|
2018
Q4 | – | Sell |
-19,000
| Closed | -$2.43M | – | 341 |
|
|
2018
Q3 | $2.43M | Buy |
+19,000
| New | +$2.43M | 0.02% | 224 |
|
|
2018
Q1 | – | Sell |
-16,100
| Closed | -$2.38M | – | 509 |
|
|
2017
Q4 | $2.38M | Sell |
16,100
-15,800
| -50% | -$2.34M | 0.02% | 231 |
|
|
2017
Q3 | $3.74M | Buy |
+31,900
| New | +$3.74M | 0.04% | 183 |
|
|
2016
Q4 | – | Sell |
-21,500
| Closed | -$2.54M | – | 542 |
|
|
2016
Q3 | $2.54M | Buy |
+21,500
| New | +$2.54M | 0.05% | 220 |
|
|
2014
Q4 | – | Sell |
-84,500
| Closed | -$10.9M | – | 450 |
|
|
2014
Q3 | $10.9M | Buy |
84,500
+32,800
| +63% | +$4.22M | 0.32% | 73 |
|
|
2014
Q2 | $4.58M | Buy |
51,700
+2,900
| +6% | +$257K | 0.15% | 104 |
|
|
2014
Q1 | $4.59M | Buy |
48,800
+12,100
| +33% | +$1.14M | 0.15% | 96 |
|
|
2013
Q4 | $4.15M | Buy |
+36,700
| New | +$4.15M | 0.15% | 80 |
|